MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,290,181 | +37.4% | 494,764 | 0.0% | 0.03% | +40.0% |
| Q2 2022 | $2,394,658 | -52.1% | 494,764 | -7.5% | 0.02% | -35.5% |
| Q1 2022 | $5,000,043 | -4.3% | 534,764 | +21.6% | 0.03% | 0.0% |
| Q4 2021 | $5,224,396 | +4.4% | 439,764 | 0.0% | 0.03% | -13.9% |
| Q3 2021 | $5,004,514 | +1723.6% | 439,764 | +2774.8% | 0.04% | +1700.0% |
| Q2 2021 | $274,428 | -95.8% | 15,297 | -97.0% | 0.00% | -97.2% |
| Q3 2020 | $6,533,000 | – | 508,423 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,156,803 | $15,279,000 | 3.01% |
| Lion Point Capital, LP | 3,684,622 | $18,959,000 | 2.16% |
| Bleichroeder LP | 1,322,463 | $6,401,000 | 1.32% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $6,926,000 | 0.81% |
| 683 Capital Management, LLC | 1,900,000 | $9,196,000 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,510,831 | $16,992,000 | 0.65% |
| Granite Point Capital Management, L.P. | 472,056 | $2,285,000 | 0.58% |
| Stonepine Capital Management, LLC | 242,327 | $1,173,000 | 0.55% |
| Avoro Capital Advisors LLC | 3,150,000 | $15,246,000 | 0.30% |
| Artal Group S.A. | 1,000,000 | $4,840,000 | 0.26% |